0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Interventional Oncology Device Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-20U7613
Home | Market Reports | Health| Health Conditions| Cancer
Global Interventional Oncology Device Market Insights Forecast to 2028
BUY CHAPTERS

Global Interventional Oncology Device Market Research Report 2024

Code: QYRE-Auto-20U7613
Report
April 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Interventional Oncology Device Market

Interventional Oncology Device refers to theOncology, like internal medicine, surgery, obstetrics and gynecology, and pediatrics, is a secondary discipline of clinical medicine. It is divided into oncology, oncology radiotherapy, and oncology surgery. Oncology is mainly engaged in medical treatment of various benign and malignant tumors; The Department of Radiation Oncology is mainly engaged in radiotherapy of tumors; oncology surgery provides surgery-based comprehensive treatment. Relevant departments of specialized cancer hospitals will be subdivided according to different parts, such as gastrointestinal oncology and lymphoma oncology in the oncology department; tumor surgery includes breast surgery, head and neck surgery, thoracic surgery, tumor gynecology, and abdominal surgery.
The global Interventional Oncology Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interventional Oncology Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interventional Oncology Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Interventional Oncology Device include AngioDynamics, Inc., BD, Boston Scientific Corporation, BTG Plc, Eckert & Ziegler BEBIG, HealthTronics, Inc., IceCure Medical, Medtronic PLC and Medwaves, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interventional Oncology Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Oncology Device.

Report Scope

The Interventional Oncology Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional Oncology Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Oncology Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Interventional Oncology Device Market Report

Report Metric Details
Report Name Interventional Oncology Device Market
Segment by Type
  • Ablation Devices
  • Embolization Devices
  • Supporting Devices
  • Next Generation Devices
Segment by Application
  • Hospitals
  • Specialty Clinics and Ambulatory Surgical Centers
  • Others (Homecare and Research Institutes)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AngioDynamics, Inc., BD, Boston Scientific Corporation, BTG Plc, Eckert & Ziegler BEBIG, HealthTronics, Inc., IceCure Medical, Medtronic PLC, Medwaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sirtex Medical Ltd., Sonacare Medical, Terumo Corporation, Trod Medical, Cook Meidical LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Interventional Oncology Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Interventional Oncology Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Interventional Oncology Device Market report?

Ans: The main players in the Interventional Oncology Device Market are AngioDynamics, Inc., BD, Boston Scientific Corporation, BTG Plc, Eckert & Ziegler BEBIG, HealthTronics, Inc., IceCure Medical, Medtronic PLC, Medwaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sirtex Medical Ltd., Sonacare Medical, Terumo Corporation, Trod Medical, Cook Meidical LLC

What are the Application segmentation covered in the Interventional Oncology Device Market report?

Ans: The Applications covered in the Interventional Oncology Device Market report are Hospitals, Specialty Clinics and Ambulatory Surgical Centers, Others (Homecare and Research Institutes)

What are the Type segmentation covered in the Interventional Oncology Device Market report?

Ans: The Types covered in the Interventional Oncology Device Market report are Ablation Devices, Embolization Devices, Supporting Devices, Next Generation Devices

1 Interventional Oncology Device Market Overview
1.1 Product Overview and Scope of Interventional Oncology Device
1.2 Interventional Oncology Device Segment by Type
1.2.1 Global Interventional Oncology Device Market Value Comparison by Type (2024-2030)
1.2.2 Ablation Devices
1.2.3 Embolization Devices
1.2.4 Supporting Devices
1.2.5 Next Generation Devices
1.3 Interventional Oncology Device Segment by Application
1.3.1 Global Interventional Oncology Device Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Specialty Clinics and Ambulatory Surgical Centers
1.3.4 Others (Homecare and Research Institutes)
1.4 Global Interventional Oncology Device Market Size Estimates and Forecasts
1.4.1 Global Interventional Oncology Device Revenue 2019-2030
1.4.2 Global Interventional Oncology Device Sales 2019-2030
1.4.3 Global Interventional Oncology Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Interventional Oncology Device Market Competition by Manufacturers
2.1 Global Interventional Oncology Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Interventional Oncology Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Interventional Oncology Device Average Price by Manufacturers (2019-2024)
2.4 Global Interventional Oncology Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Interventional Oncology Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Interventional Oncology Device, Product Type & Application
2.7 Interventional Oncology Device Market Competitive Situation and Trends
2.7.1 Interventional Oncology Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Interventional Oncology Device Players Market Share by Revenue
2.7.3 Global Interventional Oncology Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Interventional Oncology Device Retrospective Market Scenario by Region
3.1 Global Interventional Oncology Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Interventional Oncology Device Global Interventional Oncology Device Sales by Region: 2019-2030
3.2.1 Global Interventional Oncology Device Sales by Region: 2019-2024
3.2.2 Global Interventional Oncology Device Sales by Region: 2025-2030
3.3 Global Interventional Oncology Device Global Interventional Oncology Device Revenue by Region: 2019-2030
3.3.1 Global Interventional Oncology Device Revenue by Region: 2019-2024
3.3.2 Global Interventional Oncology Device Revenue by Region: 2025-2030
3.4 North America Interventional Oncology Device Market Facts & Figures by Country
3.4.1 North America Interventional Oncology Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Interventional Oncology Device Sales by Country (2019-2030)
3.4.3 North America Interventional Oncology Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Interventional Oncology Device Market Facts & Figures by Country
3.5.1 Europe Interventional Oncology Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Interventional Oncology Device Sales by Country (2019-2030)
3.5.3 Europe Interventional Oncology Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Interventional Oncology Device Market Facts & Figures by Country
3.6.1 Asia Pacific Interventional Oncology Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Interventional Oncology Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Interventional Oncology Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Interventional Oncology Device Market Facts & Figures by Country
3.7.1 Latin America Interventional Oncology Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Interventional Oncology Device Sales by Country (2019-2030)
3.7.3 Latin America Interventional Oncology Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Interventional Oncology Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Interventional Oncology Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Interventional Oncology Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Interventional Oncology Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Interventional Oncology Device Sales by Type (2019-2030)
4.1.1 Global Interventional Oncology Device Sales by Type (2019-2024)
4.1.2 Global Interventional Oncology Device Sales by Type (2025-2030)
4.1.3 Global Interventional Oncology Device Sales Market Share by Type (2019-2030)
4.2 Global Interventional Oncology Device Revenue by Type (2019-2030)
4.2.1 Global Interventional Oncology Device Revenue by Type (2019-2024)
4.2.2 Global Interventional Oncology Device Revenue by Type (2025-2030)
4.2.3 Global Interventional Oncology Device Revenue Market Share by Type (2019-2030)
4.3 Global Interventional Oncology Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Interventional Oncology Device Sales by Application (2019-2030)
5.1.1 Global Interventional Oncology Device Sales by Application (2019-2024)
5.1.2 Global Interventional Oncology Device Sales by Application (2025-2030)
5.1.3 Global Interventional Oncology Device Sales Market Share by Application (2019-2030)
5.2 Global Interventional Oncology Device Revenue by Application (2019-2030)
5.2.1 Global Interventional Oncology Device Revenue by Application (2019-2024)
5.2.2 Global Interventional Oncology Device Revenue by Application (2025-2030)
5.2.3 Global Interventional Oncology Device Revenue Market Share by Application (2019-2030)
5.3 Global Interventional Oncology Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AngioDynamics, Inc.
6.1.1 AngioDynamics, Inc. Corporation Information
6.1.2 AngioDynamics, Inc. Description and Business Overview
6.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AngioDynamics, Inc. Interventional Oncology Device Product Portfolio
6.1.5 AngioDynamics, Inc. Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Interventional Oncology Device Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Boston Scientific Corporation
6.3.1 Boston Scientific Corporation Corporation Information
6.3.2 Boston Scientific Corporation Description and Business Overview
6.3.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Corporation Interventional Oncology Device Product Portfolio
6.3.5 Boston Scientific Corporation Recent Developments/Updates
6.4 BTG Plc
6.4.1 BTG Plc Corporation Information
6.4.2 BTG Plc Description and Business Overview
6.4.3 BTG Plc Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BTG Plc Interventional Oncology Device Product Portfolio
6.4.5 BTG Plc Recent Developments/Updates
6.5 Eckert & Ziegler BEBIG
6.5.1 Eckert & Ziegler BEBIG Corporation Information
6.5.2 Eckert & Ziegler BEBIG Description and Business Overview
6.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eckert & Ziegler BEBIG Interventional Oncology Device Product Portfolio
6.5.5 Eckert & Ziegler BEBIG Recent Developments/Updates
6.6 HealthTronics, Inc.
6.6.1 HealthTronics, Inc. Corporation Information
6.6.2 HealthTronics, Inc. Description and Business Overview
6.6.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HealthTronics, Inc. Interventional Oncology Device Product Portfolio
6.6.5 HealthTronics, Inc. Recent Developments/Updates
6.7 IceCure Medical
6.6.1 IceCure Medical Corporation Information
6.6.2 IceCure Medical Description and Business Overview
6.6.3 IceCure Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IceCure Medical Interventional Oncology Device Product Portfolio
6.7.5 IceCure Medical Recent Developments/Updates
6.8 Medtronic PLC
6.8.1 Medtronic PLC Corporation Information
6.8.2 Medtronic PLC Description and Business Overview
6.8.3 Medtronic PLC Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medtronic PLC Interventional Oncology Device Product Portfolio
6.8.5 Medtronic PLC Recent Developments/Updates
6.9 Medwaves, Inc.
6.9.1 Medwaves, Inc. Corporation Information
6.9.2 Medwaves, Inc. Description and Business Overview
6.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medwaves, Inc. Interventional Oncology Device Product Portfolio
6.9.5 Medwaves, Inc. Recent Developments/Updates
6.10 Merit Medical Systems, Inc.
6.10.1 Merit Medical Systems, Inc. Corporation Information
6.10.2 Merit Medical Systems, Inc. Description and Business Overview
6.10.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Merit Medical Systems, Inc. Interventional Oncology Device Product Portfolio
6.10.5 Merit Medical Systems, Inc. Recent Developments/Updates
6.11 Sanarus Technologies, Inc.
6.11.1 Sanarus Technologies, Inc. Corporation Information
6.11.2 Sanarus Technologies, Inc. Interventional Oncology Device Description and Business Overview
6.11.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sanarus Technologies, Inc. Interventional Oncology Device Product Portfolio
6.11.5 Sanarus Technologies, Inc. Recent Developments/Updates
6.12 Sirtex Medical Ltd.
6.12.1 Sirtex Medical Ltd. Corporation Information
6.12.2 Sirtex Medical Ltd. Interventional Oncology Device Description and Business Overview
6.12.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sirtex Medical Ltd. Interventional Oncology Device Product Portfolio
6.12.5 Sirtex Medical Ltd. Recent Developments/Updates
6.13 Sonacare Medical
6.13.1 Sonacare Medical Corporation Information
6.13.2 Sonacare Medical Interventional Oncology Device Description and Business Overview
6.13.3 Sonacare Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sonacare Medical Interventional Oncology Device Product Portfolio
6.13.5 Sonacare Medical Recent Developments/Updates
6.14 Terumo Corporation
6.14.1 Terumo Corporation Corporation Information
6.14.2 Terumo Corporation Interventional Oncology Device Description and Business Overview
6.14.3 Terumo Corporation Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Terumo Corporation Interventional Oncology Device Product Portfolio
6.14.5 Terumo Corporation Recent Developments/Updates
6.15 Trod Medical
6.15.1 Trod Medical Corporation Information
6.15.2 Trod Medical Interventional Oncology Device Description and Business Overview
6.15.3 Trod Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Trod Medical Interventional Oncology Device Product Portfolio
6.15.5 Trod Medical Recent Developments/Updates
6.16 Cook Meidical LLC
6.16.1 Cook Meidical LLC Corporation Information
6.16.2 Cook Meidical LLC Interventional Oncology Device Description and Business Overview
6.16.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Cook Meidical LLC Interventional Oncology Device Product Portfolio
6.16.5 Cook Meidical LLC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Interventional Oncology Device Industry Chain Analysis
7.2 Interventional Oncology Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Interventional Oncology Device Production Mode & Process
7.4 Interventional Oncology Device Sales and Marketing
7.4.1 Interventional Oncology Device Sales Channels
7.4.2 Interventional Oncology Device Distributors
7.5 Interventional Oncology Device Customers
8 Interventional Oncology Device Market Dynamics
8.1 Interventional Oncology Device Industry Trends
8.2 Interventional Oncology Device Market Drivers
8.3 Interventional Oncology Device Market Challenges
8.4 Interventional Oncology Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Interventional Oncology Device Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Interventional Oncology Device Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Interventional Oncology Device Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Interventional Oncology Device Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Interventional Oncology Device Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Interventional Oncology Device Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Interventional Oncology Device Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Interventional Oncology Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Interventional Oncology Device, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Interventional Oncology Device, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Interventional Oncology Device, Product Type & Application
    Table 12. Global Key Manufacturers of Interventional Oncology Device, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Interventional Oncology Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology Device as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Interventional Oncology Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Interventional Oncology Device Sales by Region (2019-2024) & (K Units)
    Table 18. Global Interventional Oncology Device Sales Market Share by Region (2019-2024)
    Table 19. Global Interventional Oncology Device Sales by Region (2025-2030) & (K Units)
    Table 20. Global Interventional Oncology Device Sales Market Share by Region (2025-2030)
    Table 21. Global Interventional Oncology Device Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Interventional Oncology Device Revenue Market Share by Region (2019-2024)
    Table 23. Global Interventional Oncology Device Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Interventional Oncology Device Revenue Market Share by Region (2025-2030)
    Table 25. North America Interventional Oncology Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Interventional Oncology Device Sales by Country (2019-2024) & (K Units)
    Table 27. North America Interventional Oncology Device Sales by Country (2025-2030) & (K Units)
    Table 28. North America Interventional Oncology Device Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Interventional Oncology Device Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Interventional Oncology Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Interventional Oncology Device Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Interventional Oncology Device Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Interventional Oncology Device Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Interventional Oncology Device Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Interventional Oncology Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Interventional Oncology Device Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Interventional Oncology Device Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Interventional Oncology Device Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Interventional Oncology Device Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Interventional Oncology Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Interventional Oncology Device Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Interventional Oncology Device Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Interventional Oncology Device Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Interventional Oncology Device Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Interventional Oncology Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Interventional Oncology Device Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Interventional Oncology Device Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Interventional Oncology Device Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Interventional Oncology Device Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Interventional Oncology Device Sales (K Units) by Type (2019-2024)
    Table 51. Global Interventional Oncology Device Sales (K Units) by Type (2025-2030)
    Table 52. Global Interventional Oncology Device Sales Market Share by Type (2019-2024)
    Table 53. Global Interventional Oncology Device Sales Market Share by Type (2025-2030)
    Table 54. Global Interventional Oncology Device Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Interventional Oncology Device Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Interventional Oncology Device Revenue Market Share by Type (2019-2024)
    Table 57. Global Interventional Oncology Device Revenue Market Share by Type (2025-2030)
    Table 58. Global Interventional Oncology Device Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Interventional Oncology Device Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Interventional Oncology Device Sales (K Units) by Application (2019-2024)
    Table 61. Global Interventional Oncology Device Sales (K Units) by Application (2025-2030)
    Table 62. Global Interventional Oncology Device Sales Market Share by Application (2019-2024)
    Table 63. Global Interventional Oncology Device Sales Market Share by Application (2025-2030)
    Table 64. Global Interventional Oncology Device Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Interventional Oncology Device Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Interventional Oncology Device Revenue Market Share by Application (2019-2024)
    Table 67. Global Interventional Oncology Device Revenue Market Share by Application (2025-2030)
    Table 68. Global Interventional Oncology Device Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Interventional Oncology Device Price (US$/Unit) by Application (2025-2030)
    Table 70. AngioDynamics, Inc. Corporation Information
    Table 71. AngioDynamics, Inc. Description and Business Overview
    Table 72. AngioDynamics, Inc. Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. AngioDynamics, Inc. Interventional Oncology Device Product
    Table 74. AngioDynamics, Inc. Recent Developments/Updates
    Table 75. BD Corporation Information
    Table 76. BD Description and Business Overview
    Table 77. BD Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. BD Interventional Oncology Device Product
    Table 79. BD Recent Developments/Updates
    Table 80. Boston Scientific Corporation Corporation Information
    Table 81. Boston Scientific Corporation Description and Business Overview
    Table 82. Boston Scientific Corporation Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Boston Scientific Corporation Interventional Oncology Device Product
    Table 84. Boston Scientific Corporation Recent Developments/Updates
    Table 85. BTG Plc Corporation Information
    Table 86. BTG Plc Description and Business Overview
    Table 87. BTG Plc Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. BTG Plc Interventional Oncology Device Product
    Table 89. BTG Plc Recent Developments/Updates
    Table 90. Eckert & Ziegler BEBIG Corporation Information
    Table 91. Eckert & Ziegler BEBIG Description and Business Overview
    Table 92. Eckert & Ziegler BEBIG Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Eckert & Ziegler BEBIG Interventional Oncology Device Product
    Table 94. Eckert & Ziegler BEBIG Recent Developments/Updates
    Table 95. HealthTronics, Inc. Corporation Information
    Table 96. HealthTronics, Inc. Description and Business Overview
    Table 97. HealthTronics, Inc. Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. HealthTronics, Inc. Interventional Oncology Device Product
    Table 99. HealthTronics, Inc. Recent Developments/Updates
    Table 100. IceCure Medical Corporation Information
    Table 101. IceCure Medical Description and Business Overview
    Table 102. IceCure Medical Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. IceCure Medical Interventional Oncology Device Product
    Table 104. IceCure Medical Recent Developments/Updates
    Table 105. Medtronic PLC Corporation Information
    Table 106. Medtronic PLC Description and Business Overview
    Table 107. Medtronic PLC Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Medtronic PLC Interventional Oncology Device Product
    Table 109. Medtronic PLC Recent Developments/Updates
    Table 110. Medwaves, Inc. Corporation Information
    Table 111. Medwaves, Inc. Description and Business Overview
    Table 112. Medwaves, Inc. Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Medwaves, Inc. Interventional Oncology Device Product
    Table 114. Medwaves, Inc. Recent Developments/Updates
    Table 115. Merit Medical Systems, Inc. Corporation Information
    Table 116. Merit Medical Systems, Inc. Description and Business Overview
    Table 117. Merit Medical Systems, Inc. Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Merit Medical Systems, Inc. Interventional Oncology Device Product
    Table 119. Merit Medical Systems, Inc. Recent Developments/Updates
    Table 120. Sanarus Technologies, Inc. Corporation Information
    Table 121. Sanarus Technologies, Inc. Description and Business Overview
    Table 122. Sanarus Technologies, Inc. Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Sanarus Technologies, Inc. Interventional Oncology Device Product
    Table 124. Sanarus Technologies, Inc. Recent Developments/Updates
    Table 125. Sirtex Medical Ltd. Corporation Information
    Table 126. Sirtex Medical Ltd. Description and Business Overview
    Table 127. Sirtex Medical Ltd. Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Sirtex Medical Ltd. Interventional Oncology Device Product
    Table 129. Sirtex Medical Ltd. Recent Developments/Updates
    Table 130. Sonacare Medical Corporation Information
    Table 131. Sonacare Medical Description and Business Overview
    Table 132. Sonacare Medical Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Sonacare Medical Interventional Oncology Device Product
    Table 134. Sonacare Medical Recent Developments/Updates
    Table 135. Terumo Corporation Corporation Information
    Table 136. Terumo Corporation Description and Business Overview
    Table 137. Terumo Corporation Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Terumo Corporation Interventional Oncology Device Product
    Table 139. Terumo Corporation Recent Developments/Updates
    Table 140. Trod Medical Corporation Information
    Table 141. Trod Medical Description and Business Overview
    Table 142. Trod Medical Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Trod Medical Interventional Oncology Device Product
    Table 144. Trod Medical Recent Developments/Updates
    Table 145. Cook Meidical LLC Corporation Information
    Table 146. Cook Meidical LLC Description and Business Overview
    Table 147. Cook Meidical LLC Interventional Oncology Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Cook Meidical LLC Interventional Oncology Device Product
    Table 149. Cook Meidical LLC Recent Developments/Updates
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Interventional Oncology Device Distributors List
    Table 153. Interventional Oncology Device Customers List
    Table 154. Interventional Oncology Device Market Trends
    Table 155. Interventional Oncology Device Market Drivers
    Table 156. Interventional Oncology Device Market Challenges
    Table 157. Interventional Oncology Device Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Interventional Oncology Device
    Figure 2. Global Interventional Oncology Device Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Interventional Oncology Device Market Share by Type in 2023 & 2030
    Figure 4. Ablation Devices Product Picture
    Figure 5. Embolization Devices Product Picture
    Figure 6. Supporting Devices Product Picture
    Figure 7. Next Generation Devices Product Picture
    Figure 8. Global Interventional Oncology Device Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Interventional Oncology Device Market Share by Application in 2023 & 2030
    Figure 10. Hospitals
    Figure 11. Specialty Clinics and Ambulatory Surgical Centers
    Figure 12. Others (Homecare and Research Institutes)
    Figure 13. Global Interventional Oncology Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Interventional Oncology Device Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Interventional Oncology Device Sales (2019-2030) & (K Units)
    Figure 16. Global Interventional Oncology Device Average Price (US$/Unit) & (2019-2030)
    Figure 17. Interventional Oncology Device Report Years Considered
    Figure 18. Interventional Oncology Device Sales Share by Manufacturers in 2023
    Figure 19. Global Interventional Oncology Device Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Interventional Oncology Device Players: Market Share by Revenue in 2023
    Figure 21. Interventional Oncology Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Interventional Oncology Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Interventional Oncology Device Sales Market Share by Country (2019-2030)
    Figure 24. North America Interventional Oncology Device Revenue Market Share by Country (2019-2030)
    Figure 25. United States Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Interventional Oncology Device Sales Market Share by Country (2019-2030)
    Figure 28. Europe Interventional Oncology Device Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Interventional Oncology Device Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Interventional Oncology Device Revenue Market Share by Region (2019-2030)
    Figure 36. China Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Interventional Oncology Device Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Interventional Oncology Device Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Interventional Oncology Device Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Interventional Oncology Device Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Interventional Oncology Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Interventional Oncology Device by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Interventional Oncology Device by Type (2019-2030)
    Figure 57. Global Interventional Oncology Device Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Interventional Oncology Device by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Interventional Oncology Device by Application (2019-2030)
    Figure 60. Global Interventional Oncology Device Price (US$/Unit) by Application (2019-2030)
    Figure 61. Interventional Oncology Device Value Chain
    Figure 62. Interventional Oncology Device Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Lymphoma Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10S14319
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Gene Therapy on Cancer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3X14503
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Internal Radiotherapy Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10C14318
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Remote Afterloading System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34B7845
Sun May 19 00:00:00 UTC 2024

Add to Cart